Allen Li: Can Treating a Positive ctDNA in Colorectal Cancer Change Clinical Outcome?
Allen Li / X

Allen Li: Can Treating a Positive ctDNA in Colorectal Cancer Change Clinical Outcome?

Allen Li, Medical Oncologist at The Vancouver Clinic and Creator of Oncology AI Lab, shared a post on X:

“Can treating a positive ctDNA in colorectal cancer change clinical outcome?

In Nature Medicine: ALTAIR tested starting Lonsurf vs placebo when ctDNA turns positive in resected colorectal cancer.”

Watch here

Title: Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

Authors: Hideaki Bando, Jun Watanabe, Yusuke Takahashi, Masahito Kotaka, Nobuhisa Matsuhashi, Eiji Oki, Yoshito Komatsu, Manabu Shiozawa, Keiji Hirata, Yuji Miyamoto, Masanobu Takahashi, Kentaro Yamazaki, Dai Manaka, Akiyoshi Kanazawa, Yi-Hsin Liang, Kun-Huei Yeh, Yuko Watsuji, Yuko Yamamoto, Makoto Fukui, Shruti Sharma, Vasily N. Aushev, Adham Jurdi, Matthew Rabinowitz, Minetta C. Liu, Alexey Aleshin, Ichiro Takemasa, Daisuke Kotani, Akihiro Sato, Toshihiro Misumi, Yoshiaki Nakamura, Qian Shi, Hiroya Taniguchi, Takayuki Yoshino and Takeshi Kato.

Read the article

Allen Li

Other articles about GI Oncology on OncoDaily.